drugset / Trial / NCT03479320
Usefulness of Lidocaine in Oral and Maxillofacial Surgeries Under General Anesthesia for Pain Control After Operation
RandomizedParallel-groupDouble-blindTreatment
Summary
This will be a randomized double blinded clinical study conducted in patients undergoing oral and maxillofacial surgery under general anesthesia. Lidocaine group will receive intravenous bolus 1.5 mg/kg at induction followed by continuous infusion of 2 mg/kg/hr until the completion of surgery.Normal saline group will receive same amount of intravenous normal saline .The primary outcome will be postoperative pain using the NRS scale during first 24 hours and time to first analgesic request
Timeline
- Start
- 2018-03-28
- Primary completion
- 2018-12-27
- Completion
- 2019-03-27
Outcome
Missed primary endpoint
paper does not have significant effect on reduction in postoperative pain intensity and analgesic consumption PMID 39376771 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 mg/kg | Intravenous |